Darvadstrocel

Darvadstrocel is a type of cell therapy product that is used to help heal chronic wounds. It is made from a patient's own fat cells and is injected into the wound site to help stimulate healing. The product is composed of the patient’s own adipose (fat) tissue, which is modified to contain specific cell types with wound healing properties. These cell types can be activated by the body’s own wound healing environment. The product is injected directly into the wound site and can help stimulate healing and regenerate tissue. Darvadstrocel has been used in the past to help with the healing of diabetic foot ulcers, venous leg ulcers, and other chronic wounds. It has also been used to help improve wound healing following reconstructive surgery, such as skin grafts.

Darvadstrocel (also known by the brand name Alofisel) is a medication used to treat a specific condition:

  • Complex Perianal Fistulas in Adults with Crohn's Disease: These are abnormal tunnel-like connections that develop between the anus and the skin around it (perianal) in people with Crohn's disease, a chronic inflammatory bowel disease (IBD). These fistulas can be painful and difficult to heal.

Here's a breakdown of how Darvadstrocel works and how it's used:

Function:

  • Darvadstrocel is a type of cell therapy medication. It consists of a suspension of allogeneic adipose-derived stem cells (eASC). These are mesenchymal stem cells derived from the fatty tissue (adipose tissue) of healthy donors.

Mechanism of Action:

  • The exact mechanism by which Darvadstrocel works is still under investigation. However, it's believed that the transplanted stem cells promote tissue regeneration and healing in the fistula tract, ultimately leading to its closure.

Applications:

  • Darvadstrocel is only approved for use in adults with Crohn's disease who have complex perianal fistulas that have not responded adequately to conventional or biologic therapies.
  • Conventional therapies may include antibiotics, anti-inflammatory medications, and dietary changes. Biologic therapies target specific molecules involved in the inflammatory process of Crohn's disease.

Administration:

  • Darvadstrocel is administered as a single dose injection into the fistula tract by a healthcare professional.
  • Before the injection, the fistula tract is usually cleaned and prepared.

Important Considerations:

  • Darvadstrocel is a relatively new medication, and long-term data on its safety and efficacy are still emerging.
  • Potential side effects associated with Darvadstrocel include pain, swelling, and infection at the injection site. There's also a small risk of allergic reactions.
  • Darvadstrocel is not a cure for Crohn's disease, but it can help heal complex perianal fistulas and improve symptoms.

Additional Notes:

  • Darvadstrocel is a prescription medication and should only be used under the supervision of a doctor experienced in treating Crohn's disease and familiar with this specific therapy.
  • It's important to discuss the potential benefits and risks of Darvadstrocel with your doctor to determine if it's the right treatment option for you.

In Conclusion:

Darvadstrocel offers a promising new approach for treating complex perianal fistulas in adults with Crohn's disease. However, it's a specialized therapy with considerations, and consulting a healthcare professional is crucial for proper evaluation and treatment decisions.
 

Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L04 Immunosuppressants
L04A - Immunosuppressants
L04AX Other immunosuppressants
External Links